IFAPP Academy Faculty, Sandor Kerpel-Fronius, MD, D.Sc.

Sandor Kerpel-Fronius

M.D., D.Sc.

Professor of Clinical Pharmacology. Department of Pharmacology and Pharmacotherapy. Semmelweis Medical University. Budapest, Hungary


Dr. Kerpel-Fronius obtained medical diploma and board certifications in Clinical Laboratory Sciences and Clinical Pharmacology at Semmelweis University. He developed an extensive work experience in experimental research in neurobiology at the Semmelweis University, then at Karolinska Institute, Stockholm and later on as Sloan Fellow at the Maryland Psychiatric Research Center in the US. Later he organized a clinical pharmacology research group at the National Institute of Oncology in Hungary and worked on a sabbatical year at the Cancer Center of the Wayne State University, Detroit, US. He obtained D.Sc. degree from the Hungarian Academy of Sciences.

Dr. Kerpel-Fronius has worked extensively in clinical drug development both at the Hungarian National Institute of Oncology and later within the international pharmaceutical industry in Europe. In 2001 he became Professor of Clinical Pharmacology at the Department of Pharmacology and Pharmacotherapy of the Semmelweis University, Budapest, Hungary. For a short time he also worked as the General Director of the Hungarian Drug Regulatory Agency (Hungarian National Institute of Pharmacy).

In addition to his academic activities, he currently is active as counselor at the IFAPP Board of Officers, Executive board Member of PharmaTrain Federation. He serves as Vice President of the Alliance for Clinical Research of Excellence and Safety (ACRES). For several years he was member of the Educational Subcommittee of the European Association for Clinical Pharmacology and Therapeutics, the Executive Board of the IMI-PharmaTrain and invited expert of the OECD Governance of Clinical trials. In 2016 he was elected to become Honorary Fellow of the Faculty of Pharmaceutical Medicine (FPM) of the Royal Colleges of Physicians of the United Kingdom.